Displaying 176 - 179 of 179
Thu 06 October 2011
Pancreatic Cancer UK is deeply saddened by Steve Jobs' death after a long battle with pancreatic cancer.Read More about 'Steve Jobs dies aged 56 from pancreatic cancer'
Wed 07 September 2011
Outcomes for pancreatic cancer patients in the UK fall well below acceptable levels according to Pancreatic Cancer UK's Study for Survival. By launching the Campaign for Hope, Pancreatic Cancer UK is setting an ambitious goal to double survival rates for UK pancreatic cancer patients within five years.Read More about 'Pancreatic Cancer UK launch Campaign For Hope'
Tue 02 August 2011
Research undertaken at the University of Vermont (UVM) and the Dartmouth-Hitchcock Medical Centre (DHMC) in New England has shown that using a tumour marker, serum CA 19-9, combined with an endoscopic ultrasound if the tumour marker is elevated, is more likely to detect stage 1 pancreatic cancer in a high-risk population than by using the standard means of detection.Read More about 'Top US medical centres progress pancreatic cancer detection'
Wed 27 July 2011
Pancreatic Cancer UK welcomes the launch of a new trial for patients with advanced pancreatic cancer in the UK.Read More about 'New UK trial for advanced pancreatic cancer patients'